Journals / Bakırköy Tıp Dergisi / 2021 / Cilt: 17 - Sayı: 1

Risk Factors for Malignant Gallbladder Polyps

Malign Safra Kesesi Polipleri için Risk Faktörleri

Pages
30–35
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean polyp size was 7.47±5.51 mm in Group 1 and 12.46±1.89 mm in Group 2, with a significant difference (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to determine risk factors for malignancy in gallbladder polyps.Method: 92 patients who underwent laparoscopic cholecystectomy due to gallbladder polyp were retrospectively analyzed.
📊
Key Findings & Data:Demographic data of the patients, size and number of polyp, the presence of gallstones and histopathological features of the polyps were recorded.Results: 92 patients were included.
💡
Conclusion & Impact:Mean polyp size was 7.47±5.51 mm in Group 1 and 12.46±1.89 mm in Group 2, with a significant difference (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to determine risk factors for malignancy in gallbladder polyps.Method: 92 patients who underwent laparoscopic cholecystectomy due to gallbladder polyp were retrospectively analyzed. Demographic data of the patients, size and number of polyp, the presence of gallstones and histopathological features of the polyps were recorded.Results: 92 patients were included. Mean age was 45.78±11.21 years (21-72). 59 of the patients (64.1%) were female and 33 (35.9%) were male. Mean polyp size was 8.17±2.19 mm and 35 patients (38.0%) had a single polyp, while 57 (62.0%) had multiple polyps (≥2). 47 of the patients (51.1%) had gallstone disease, while 45 (48.9%) had no stone disease. Benign polyps (Group 1) were found in 79 patients (85.9%) and adenocarcinomas (Group 2) were found in 13 (14.1%). Of the benign polyps, 71 (77.1%) were non-neoplastic polyps and 8 (8.8%) were neoplastic polyps (adenomas). Of the 13 patients with adenocarcinomas, 11 (11.9%) were T1a and 2 (2.2%) were T1b. Mean age was 44.32±11.03 years in Group 1 and 54.61±8.07 years in Group 2, the latter being significantly older (p=0.002). Mean polyp size was 7.47±5.51 mm in Group 1 and 12.46±1.89 mm in Group 2, with a significant difference (p

Özet

Amaç: Bu çalışmanın amacı safra kesesi poliplerinde malignite için risk faktörlerini belirlemektir.Yöntem: Safra kesesi polipi nedeniyle laparoskopik kolesistektomi uygulanan 92 hasta geriye dönük olarak incelendi. Hastaların demografik verileri, polip boyutu ve sayısı, safra taşı varlığı ve poliplerin histopatolojik özellikleri kaydedildi.Bulgular: 92 hasta dahil edildi. Ortalama yaş 45,78 ± 11,21 yıl (21-72) idi. Hastaların 59'u (64.1%) kadın, 33'ü (35.9%) erkekti. Ortalama polip boyutu 8.17 ± 2.19 mm ve 35 hastada (38.0%) tek polip varken 57 hastada (62.0%) çoklu polip (≥2) vardı. Hastaların 47'sinde (51.1%) safra taşı hastalığı varken 45'inde (48.9%) taş hastalığı yoktu. Benign polipler (Grup 1) 79 hastada (85,9%), adenokarsinomlar (Grup 2) 13 (14,1%) hastada saptandı. Benign poliplerin 71'i (77,1%) neoplastik olmayan polip ve 8'i (8,8%) neoplastik polip (adenom) idi. Adenokarsinomlu 13 hastanın 11'i (11.9%) T1a ve 2'si (2.2%) T1b idi. Grup 1'de ortalama yaş 44,32 ± 11,03, Grup 2'de 54,61 ± 8,07 yıldı ve Grup 2'de anlamlı olarak daha yaşlıydı (p = 0,002). Ortalama polip boyutu Grup 1'de 7,47 ± 5,51 mm, Grup 2'de 12,46 ± 1,89 mm idi ve anlamlı bir farkla (p

🔖

Cite This Article

BÖLÜKBAŞI, H., YILMAZ, S., BOZKURT, M. A. (2022). Risk Factors for Malignant Gallbladder Polyps. Bakırköy Tıp Dergisi, Cilt: 17 - Sayı: 1, 30–35. https://ajindex.com/articles/459965

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002;16(3):187-94. doi: 10.1155/2002/787598
  2. Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol. 1970;90(5):423-32. PMID: 4319984
  3. Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallbladder. Am J Surg. 2004;188(2):186-90. doi: 10.1016/j.amjsurg.2003.11.043
  4. Wan YL, Wang WZ, Li T, Tang XY. Polypoid lesions of the gallbladder. Chin J Surg. 1989;27(8):450-3. PMID: 2695314
  5. Koga A, Watanabe K, Fukuyama T, Takiguchi S, Nakayama F. Diagnosis and operative indications for polypoid lesions of the gallbladder. Arch Surg. 1988;123(1):26-9. doi: 10.1001/archsurg.1988.01400250028003
  6. Kubota K, Bandai Y, Noie T, Ishizaki Y, Teruya M, Makuuchi M. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery. 1995;117(5):481-7. doi: 10.1016/s0039-6060(05)80245-4
  7. Csendes A, Burgos AM, Csendes P, Smok G, Rojas J. Late follow-up of polypoid lesions of the gallbladder smaller than 10mm. Ann Surg. 2001;234(5):657-60. doi: 10.1097/00000658-200111000-00011
  8. Terzi C, Sokmen S, Seckin S, Albayrak L, Uğurlu M. Polypoid lesions of the gallbladder: report of 100 cases with special reference to operative indications. Surgery. 2000;127(6):622-7. doi: 10.1067/msy.2000.105870
  9. Lu D, Radin R, Yung E, Tchelepi H. Malignant transformation of a 5-mm gallbladder polyp over 2 years: a case report and review of current literature. Ultrasound Q. 2015;31(1):66-8. doi: 10.1097/RUQ.0000000000000094
  10. Kasle D, Rahnemai-Azar AA, Bibi S, Gaduputi V, Gilchrist BF, Farkas DT. Carcinoma in situ in a 7 mm gallbladder polyp: time to change current practice. World J Gastrointest Endosc. 2015;7(9):912-5. doi: 10.4253/wjge.v7.i9.912
  11. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-99. doi: 10.3322/caac.21388
  12. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211-7. doi: 10.3748/wjg.v21.i43.12211
  13. Ito H, Matros E, Brooks DC, Osteen RT, Zinner MJ, Swanson RS, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastroint